BIIB vs TBLAW · P/E 21, rev $9.89B vs rev $1.91B
Biogen Inc (BIIB) versus Taboola.com Ltd. Warrant (TBLAW) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Taboola.com Ltd. Warrant (TBLAW) common stock listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported TBLAW revenue for 2025-12-31 was $1.91B. Net income was $42.3M. Revenue was up 8.3% from 2024-12-31 to 2025-12-31.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Not investment advice. Open the BIIB and TBLAW stock pages for the full models.
Not investment advice.